Main menu

One solution — from R&D, to QC

Identity, integrity, and hidden risks, all in one view.

Cell and gene therapy development presents significant complexity. Next-generation sequencing (NGS) is essential as a critical quality control (QC) checkpoint throughout development — helping ensure product consistency, efficacy, and safety.


Brochure: biopharma CGT — 2 pages

Cell and gene guide

Learn how our sequencing technology delivers ultra-rich, multiomic data for comprehensive insights. Resolve complex questions fast with simple solutions driven by data.


Don't take our word for it

Application of nanopore long-read sequencing to sterility testing for cell therapy products

Breaking barriers in cell & gene therapy

Recent publications


Accuracy you can trust — insights you can act on

Long reads spanning entire plasmids and AAV genomes reveal structure, orientation, and sequence continuity — helping teams understand not only what’s present, but how it may behave within complex therapeutic systems.


入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

联系我们

知识产权 Cookie 政策 企业报告 隐私政策 条件条款 Modern slavery policy 前瞻性陈述

关于 Oxford Nanopore

联系我们 领导团队 媒体资源和联系方式 投资者 在 Oxford Nanopore 工作 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag